UNICLINICS INTERNATIONAL LTD

Company Registration Number:
12874799 (England and Wales)

Unaudited micro entity accounts for the year ended 30 September 2024

Period of accounts

Start date: 01 October 2023

End date: 30 September 2024

UNICLINICS INTERNATIONAL LTD

Contents of the Financial Statements

for the Period Ended 30 September 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

UNICLINICS INTERNATIONAL LTD

Company Information

for the Period Ended 30 September 2024




Director: Maksym Isaiev
Registered office: 85
Great Portland Street
First Floor
London
GBR
W1W 7LT
Company Registration Number: 12874799 (England and Wales)

UNICLINICS INTERNATIONAL LTD

Directors' Report Period Ended 30 September 2024

The directors present their report with the financial statements of the company for the period ended 30 September 2024

Principal Activities

The principal activity of the COMPANY in the Year Ended under review was that of Travel agency activities.

Directors

The directors shown below have held office during the whole of the period from 01 October 2023 to 30 September 2024
Maksym Isaiev

This report was approved by the board of directors on 4 November 2024
And Signed On Behalf Of The Board By:

Name: Maksym Isaiev
Status: Director

UNICLINICS INTERNATIONAL LTD

Profit and Loss Account

for the Period Ended 30 September 2024


2024
£

2023
£
Turnover 292,312 477,895
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 167
Cost of Materials ( 286,113 ) ( 471,641 )
Staff Costs ( 0 ) ( 0 )
Depreciation and Writeoffs ( 0 ) ( 334 )
Other charges ( 2,508 ) ( 1,362 )
Tax on Profit ( 1,178 ) ( 898 )
Profit or (Loss) for Period 2,513 3,827

UNICLINICS INTERNATIONAL LTD

Balance sheet

As at 30 September 2024


2024
£

2023
£
Called up share capital not paid: 0 0
Fixed Assets: 1,000 1,000
Current assets: 41,563 39,055
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 0 ) ( 0 )
Net current assets (liabilities): 41,563 39,055
Total assets less current liabilities: 42,563 40,055
Creditors: amounts falling due after more than one year: ( 73,119 ) ( 75,627 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): ( 30,556 ) ( 35,572 )
Capital and reserves: ( 30,556 ) ( 35,572 )

UNICLINICS INTERNATIONAL LTD

Balance sheet continued

For the year ending 30 September 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 4 November 2024
And Signed On Behalf Of The Board By:

Name: Maksym Isaiev
Status: Director

The notes form part of these financial statements

UNICLINICS INTERNATIONAL LTD

Footnotes to the Financial Statements

for the Period Ended 30 September 2024

  • 1. Employee Information

    Average number of employees: 0

UNICLINICS INTERNATIONAL LTD

Footnotes to the Financial Statements

for the Period Ended 30 September 2024

  • 2. Off balance sheet disclosure

    No